5398 篇
13910 篇
478050 篇
16308 篇
11770 篇
3941 篇
6548 篇
1253 篇
75656 篇
37910 篇
12167 篇
1665 篇
2868 篇
3421 篇
641 篇
1241 篇
1980 篇
4921 篇
3875 篇
5491 篇
全球肾上腺素自动注射器市场报告(2017-2021年)
Global Epinephrine Autoinjector Market 2017-2021
Epinephrine is among the first line of treatment drugs for anaphylactic conditions and is considered a life-saving drug during emergencies. Epinephrine autoinjectors have proved to be a life savior for people with severe allergies from as early as the 1980s.
The global epinephrine autoinjector market has been witnessing continuous technological innovations and developments over the years, after the first FDA approval of EpiPen in 1987. The global epinephrine autoinjector market is growing at a steady rate and is projected to grow at a CAGR of 14.58%, during the forecast period.The market which is still in its nascent stage in APAC provides many penetration
opportunities for the global vendors.
PART 01: Executive summary 6
PART 02: Scope of the report 19
Market overview 19
Top-vendor offerings 20
PART 03: Market research methodology 21
Research methodology 21
Economic indicators 21
PART 04: Introduction 22
Key market highlights 22
Epinephrine autoinjector: Overview 25
PART 05: Market landscape 28
Market overview 28
Market size and forecast 30
Five forces analysis 32
PART 06: Market segmentation by dosage 33
Global epinephrine autoinjector market by 0.15gm
dosage 35
Global epinephrine autoinjector market by 0.30gm
dosage 36
Global epinephrine autoinjector market by 0.5gm
dosage 37
PART 07: Market segmentation by age group 39
PART 08: Market segmentation by end-user 40
Hospitals and clinics 40
Individuals 41
PART 09: Geographical segmentation 42
Epinephrine autoinjector market in the Americas 43
Epinephrine autoinjector market in EMEA 47
Epinephrine autoinjector market in APAC 49
PART 10: Market drivers 52
Increasing prevalence of allergies 52
Technological advances 53
Marketing strategies 54
PART 11: Impact of drivers 56
PART 12: Market challenges 57
Product recalls and regulatory issues 57
Presence of substitutes 58
High cost 59
PART 13: Impact of drivers and challenges 60
PART 14: Market trends 61
Tentative product launches 61
Growing awareness about epinephrine autoinjectors 62
Patient assistance programs 63
PART 15: Vendor landscape 64
Competitive scenario 64
Key news 67
Geographical presence of key vendors 68
PART 16: Key vendor analysis 69
ALK-Abelló 69
Impax Laboratories 72
Lincoln Medical 75
Mylan 78
Other prominent vendors 81
PART 17: Appendix 82
List of abbreviations 82
PART 18: Explore Technavio 83